Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

July 27 2012

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

July 23, 2012

High dietary antioxidant intake might cut pancreatic cancer risk
Increasing dietary intake of the antioxidant vitamins C, E, and selenium could help cut the risk of developing pancreatic cancer by up to two thirds, suggests research published online in the journal Gut.
Read article at medicalxpress.com

Comment: To read an overview of the most recent research and clinical studies on the health benefits of micronutrients in fighting pancreatic cancer, click here.

July 23, 2012

B12 supplements may help in battle against hepatitis C
Adding vitamin B12 to standard hepatitis C virus (HCV) treatment significantly boosts the body's ability to keep the virus at bay, according to a new pilot study published in Gut.
Read article at nutraingredients.com

Comment: To read additional research and clinical studies on the natural treatment of hepatitis and other liver problems, click here and here.

July 23, 2012

Omega-3s may protect children against allergies: Human data
Daily supplements of omega-3-rich fish oil may reduce the allergic response to some allergens, says a new study that adds to the immune modulating properties of the fatty acids.
Read article at nutraingredients-usa.com

Comment: To read an overview of the most recent research and clinical studies on the health benefits of micronutrients in fighting allergies, click here.

July 18, 2012

Micronutrient powder effective in combating anaemia: study
Mixing micronutrient powder into infants’ complementary food reduces rates of anaemia beyond what nutrition education alone can achieve, according to University of Otago-led research involving more than 3000 Cambodian under two year olds.
Read article at medicalxpress.com

Comment: To read additional research and clinical studies on the natural treatment of anaemia, click here and here.

July 7, 2012

Vitamin D could be simple solution for multiple sclerosis
Some neurologists believe that the debilitating forms of multiple sclerosis (MS) could soon come to an end thanks to vitamin D.
Read article on the newstrackindia.com website

Comment: To read scientific studies showing how vitamin D and other essential micronutrients can fight multiple sclerosis, click here and here.

For more natural health news, click here.
See also our 2001-2011 news archive, by clicking here.

Pharma "Business with Disease" News

July 21, 2012

The patients ditching statins 'due to painful side effects of the cholesterol-lowering drugs that have left some bedridden'
Painful side effects from taking statins are far more common than experts thought, a study suggests. Patients reported coming off the cholesterol-lowering drugs after experiencing debilitating muscle pain and cramps, which in some cases left them unable to carry out everyday tasks or even bed-ridden.
Read article in the Daily Mail (UK)

Comment: Cholesterol-lowering drugs are one of the largest business segments of the global pharmaceutical drug business. This entire business is built on fear – the fear that cholesterol actually causes heart attacks. While the “cholesterol-scare” has become a gold mine for the Pharma Cartel, the economic burden of this business is ultimately carried by us, the people. To learn the facts about cholesterol and statins, click here. To read about Dr. Rath’s scientific discovery that coronary heart disease occurs for exactly the same reason that clinical (early) scurvy does – a deficiency of vitamin C in the cells composing the artery wall – click here.

July 21, 2012

Pfizer Loses Prempro Ruling, Must Pay $10.4 Million
Pfizer must pay $10.4 million in damages to a woman who blamed the company’s Prempro menopause drug for her breast cancer, an appeals court said.
Read article at bloomberg.com

July 20, 2012

Anemia drugs made billions, but at what cost?
For years, a trio of anemia drugs known as Epogen, Procrit and Aranesp ranked among the best-selling prescription drugs in the United States, generating more than $8 billion a year for two companies, Amgen and Johnson & Johnson. Even compared with other pharmaceutical successes, they were superstars. For several years, Epogen ranked as the single costliest medicine under Medicare: U.S. taxpayers put up as much as $3 billion a year for the drugs. The trouble, as a growing body of research has shown, is that for about two decades, the benefits of the drug — including “life satisfaction and happiness” according to the FDA-approved label — were wildly overstated, and potentially lethal side effects, such as cancer and strokes, were overlooked.
Read article in The Washington Post (USA)

July 19, 2012

Report: J&J will pay $2.2B in Risperdal settlement
Johnson & Johnson has agreed to pay as much as $2.2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal, according to a published report. The Wall Street Journal, which reported the settlement Thursday, said the settlement will include a $400 million criminal fine and that the final amount will depend on how many states accept the settlement.
Read article in the Houston Chronicle (USA)

July 18, 2012

Multiple Sclerosis Meds Fail To Slow Progression
Three medicines that are widely prescribed to combat multiple sclerosis failed to reduce the progression of the disabling disease in a newly released study. And the findings amount to a setback for three drugmakers whose treatments have collectively generated billions of dollars in annual sales for the past several years. The drugs include Avonex, which made by Biogen Idec; Betaseron, which is sold by Bayer, and the Rebif medication marketed by Merck KGaA.
Read article at pharmalot.com

Comment: Unlike the conventional medicine approach to disease, which focuses on controlling symptoms, Dr. Rath’s Cellular Medicine approach is based upon the scientific understanding that chronic deficiencies of vitamins, amino acids and other essential micronutrients are the primary cause of today’s most common chronic diseases. This innovative approach to human health is based on a new understanding of the basis of health and disease in the human body: health and disease are determined at the level of the millions of cells from which our bodies are built, and not at the level of organs. To read scientific studies showing how essential micronutrients can fight multiple sclerosis, click here and here.

July 12, 2012

IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly $1.2 Trillion By 2016
Following several years of slowing growth, the global market for medicines is poised to rebound from an expected low point of 3-4 percent growth in 2012 to 5-7 percent in 2016, according to a new forecast issued by the IMS Institute for Healthcare Informatics. The report, The Global Use of Medicines: Outlook through 2016, found that annual global spending on medicines will rise from $956 billion in 2011 to nearly $1.2 trillion in 2016, representing a compound annual growth rate of 3-6 percent.
Read press release at imshealth.com

Comment: As this press release shows, total global drug sales for the Pharma Cartel during 2011 were worth 956 billion dollars. To put this extraordinary amount of money into context, it represents a sum that exceeds the combined gross domestic product (GDP) of the world’s 120 poorest countries. Furthermore, by 2016, global sales are forecast to reach nearly 1.2 TRILLION dollars per year (i.e. 1,200 billion, or 1,200,000,000,000). It is worth remembering these facts the next time someone asks you to donate money to a charity for research into new drug treatments. After all, with astronomical sales figures like these, the "business with disease" is clearly not short of funds for research. For an analysis of the Pharma Cartel's global sales figures between 2003 and 2011, click here.

For more pharma "business with disease" news, click here.
See also our 2001-2011 news archive, by clicking here.

GMO News

July 19, 2012

Battle over genetically engineered food heading to voters
California could become the first state to require labels on genetically modified, or GMO, food products. Firms on both sides are gearing up for campaigns.
Read article in the Los Angeles Times (USA)

July 9, 2012

Former Monsanto Employee Warns Of Genetically Modified Food Concerns
A former Monsanto employee, Kirk Azevedo, came forward for an interview with Food Nation Radio Network to give our listeners insight into how Monsanto does business. During the time he was employed there with some of the best minds in the biotech industry, he became alarmed by some of the practices Monsanto used to test new GMO crops, how those crops were disposed of after testing, and more.
Read article and listen to interview on the CBS Tampa website (USA)

For more GMO news, click here.
See also our 2001-2011 news archive, by clicking here.

Other Health-related News

July 19, 2012

Big doses needed for elimination of low vitamin D levels for African Americans: Study
Over 90% of African Americans may have vitamin D deficiency, and daily doses of 4,000IU may be needed to eliminate deficiency, says a new study from the Medical University of South Carolina.
Read article at nutraingredients-usa.com

July 18, 2012

Study of psychosis risk and brain to track effects of Omega-3 pills
The first major study on the biological effects of omega-3 fatty acids on the human brain is focusing on the role that this natural substance, primarily found in fish oil, may play in fighting psychosis.
Read article at medicalxpress.com

July 5, 2012

BASF, Shell told to pay $525 million by Brazil court
German chemicals maker BASF and oil major Shell have been told by a Brazilian court to pay 1.06 billion Brazilian real ($525.23 million) into a compensation fund for former employees at a pesticides plant who said their health suffered from working there.
Read Reuters news report at yahoo.com

For more health-related news, click here.
See also our 2001-2011 news archive, by clicking here.

Political News

July 21, 2012

£13tn: hoard hidden from taxman by global elite
A global super-rich elite has exploited gaps in cross-border tax rules to hide an extraordinary £13 trillion ($21tn) of wealth offshore – as much as the American and Japanese GDPs put together – according to research commissioned by the campaign group Tax Justice Network. James Henry, former chief economist at consultancy McKinsey and an expert on tax havens, has compiled the most detailed estimates yet of the size of the offshore economy in a new report, The Price of Offshore Revisited, released exclusively to the Observer.
Read article in The Observer (UK)

July 20, 2012

American Banks Funded the Nazis
It is newsworthy that HSBC has been accused by the Senate of laundering money for terrorists. Big banks have been caught in a wide variety of criminal activities recently. But this is nothing new.
Read article on the Centre for Research on Globalization website

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

 

Back to the Newsletter Archive…